Chan Xin Yi, Elliott Morgan B, Macklin Bria, Gerecht Sharon
Department of Chemical and Biomolecular Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, 21218, USA.
Adv Biochem Eng Biotechnol. 2018;163:147-168. doi: 10.1007/10_2017_28.
Development of pluripotent stem cells (PSCs) is a remarkable scientific advancement that allows scientists to harness the power of regenerative medicine for potential treatment of disease using unaffected cells. PSCs provide a unique opportunity to study and combat cardiovascular diseases, which continue to claim the lives of thousands each day. Here, we discuss the differentiation of PSCs into vascular cells, investigation of the functional capabilities of the derived cells, and their utilization to engineer microvascular beds or vascular grafts for clinical application. Graphical Abstract Human iPSCs generated from patients are differentiated toward ECs and perivascular cells for use in disease modeling, microvascular bed development, or vascular graft fabrication.
多能干细胞(PSCs)的发展是一项卓越的科学进步,它使科学家能够利用再生医学的力量,使用未受影响的细胞来潜在地治疗疾病。PSCs为研究和对抗心血管疾病提供了独特的机会,心血管疾病每天仍夺去数千人的生命。在此,我们讨论PSCs向血管细胞的分化、对所衍生细胞功能能力的研究,以及它们在构建用于临床应用的微血管床或血管移植物中的应用。图形摘要 从患者产生的人诱导多能干细胞分化为内皮细胞和血管周细胞,用于疾病建模、微血管床开发或血管移植物制造。